The present invention provides novel softgel capsules of a women health care hormone, as well as to a process for the preparation thereof. In particular, the present invention relates to novel softgel capsules of a women health care hormone, which are capable of reducing allergic reactions, while maintaining an adequate solubility of the hormone in the administration thereof.